Bookmark and Share

Compound Summary for: CID 449459

afimoxifene

Also known as: 4-Hydroxytamoxifen; Hydroxytamoxifen; (Z)-4-Hydroxytamoxifen; Tamogel; trans-4-Hydroxytamoxifen; 4-Monohydroxytamoxifen; Ici 79280
Molecular Formula: C26H29NO2   Molecular Weight: 387.51396   InChIKey: TXUZVZSFRXZGTL-QPLCGJKRSA-N
Afimoxifene (4-Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia. TamoGel is formulated using Enhanced Hydroalcoholic Gel (EHG) Technology. This technology enables percutaneous delivery of drugs that cannot be delivered orally. It is being developed by Ascent Therapeutics.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _